Internal Medicine · Cartersville, GA
NPI
1508959750
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
491 E Main St
Cartersville, GA, 30121
Phone (770) 387-4512
Groups this clinician bills Medicare through
Medicare paid, 2024
$167K
1,973 services
Medicare patients, 2024
396
Average age 76
Drug cost, 2024
$1.3M
13,087 prescriptions
Company payments, 2025
$1,750
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David E Kim was code 99214 (office e&m - established), 444 times for 274 patients. In total David E Kim billed 1,973 services in 33 codes, and Medicare paid $167K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 444 | 274 | $84.22 | $37K |
| 99215 Office E&M - Established | Office | 345 | 236 | $133.94 | $46K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 316 | 316 | $123.72 | $39K |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 303 | 303 | $17.68 | $5,357 |
| 99213 Office E&M - Established | Office | 258 | 161 | $57.86 | $15K |
| 99496 Chronic, Principal, and Transitional Care Management | Office | 45 | 32 | $204.64 | $9,209 |
| 96372 Injection Administration | Office | 42 | 28 | $10.28 | $432 |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 35 | 30 | $36.81 | $1,288 |
| 99212 Office E&M - Established | Office | 34 | 31 | $39.23 | $1,334 |
| G0179 Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 29 | 13 | $30.50 | $885 |
| 99205 Office E&M - New | Office | 17 | 17 | $170.65 | $2,901 |
| G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 11 | 11 | $157.49 | $1,732 |
| 69210 Other Organ Systems | Office | 11 | 11 | $30.05 | $331 |
By year: 2022 $149K for 1,753 services; 2023 $156K for 1,931 services; 2024 $167K for 1,973 services.
Medicare prescription drug claims, 2024
In 2024, the drug David E Kim prescribed most often to Medicare patients was Levothyroxine Sodium, with 837 prescriptions and refills. In total David E Kim wrote 13,087 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 837 | 2,176 | 216 | $10K |
| Rosuvastatin Calcium Generic | 387 | 975 | 116 | $4,065 |
| Gabapentin Generic | 274 | 437 | 77 | $4,284 |
| Metformin Hcl Generic | 260 | 703 | 75 | $1,665 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 257 | 257 | 48 | $4,488 |
| Amlodipine Besylate Generic | 235 | 624 | 75 | $1,174 |
| Meloxicam Generic | 230 | 570 | 91 | $1,064 |
| Losartan Potassium Generic | 230 | 636 | 69 | $2,050 |
| Lisinopril Generic | 217 | 602 | 66 | $1,458 |
| Pantoprazole Sodium Generic | 216 | 575 | 71 | $2,621 |
| Atorvastatin Calcium Generic | 206 | 552 | 64 | $1,576 |
| Alprazolam Generic | 191 | 199 | 40 | $674 |
| Tramadol Hcl Generic | 189 | 191 | 48 | $1,789 |
| Furosemide Generic | 185 | 380 | 62 | $677 |
| Ozempic Semaglutide | 181 | 251 | 37 | $231K |
Brand drugs: 1,746 claims; generic drugs: 11,221 claims; opioid claims: 687.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David E Kim $1,750 ($1,750 in general payments such as food, travel and fees) from 21 companies. The largest payer was Novo Nordisk Inc with $323.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 12 | $323 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $223 |
| Axsome Therapeutics, Inc. AXSM | 5 | $192 |
| Abbvie Inc. ABBV | 9 | $150 |
| Pfizer Inc. PFE | 9 | $141 |
| Ardelyx, Inc. ARDX | 1 | $128 |
| Lilly USA, LLC LLY | 6 | $91.42 |
| Corcept Therapeutics CORT | 3 | $76.86 |
| Amgen Inc. AMGN | 4 | $61.99 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 3 | $58.6 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.